If symptoms spread beyond the site or breathing is affected, seek emergency care immediately
Technical Specifications Compounds Included: GHK-Cu, BPC-157, TB-500 Total Peptide Content: 70 mg (50mg GHK-Cu, 10mg BPC-157, 10mg TB-500) Format: Lyophilized peptide blend Purity: 9899% (COA included) Appearance: Blue-tinted and white lyophilized peptide mixture Category: Research peptide reagent Intended Use Approved for: Laboratory experimentation In-vitro biochemical assays Multi-pathway mechanistic studies Preclinical, non-human research modeling Advanced peptide interaction analysis Academic or institutional research Not approved for: Human or veterinary consumption Injection, ingestion, inhalation, or topical application Cosmetic, dermatological, or therapeutic purposes Any clinical or medical application This product is not approved by FDA, Health Canada, or similar regulatory bodies for human use
The siRNAs sequences were as follows: NC, forward, 5-UUCUCCGAACGUGUCACGUTT-3, reverse, 5-ACGUGACACGUUCGGAGAATT-3
Colorectal cancer (CRC) caused by a number of genetic disorders, including KRAS mutation, p53 mutation, and p53 depletion, which provides additional evidence for the survival-promoting function of p53
